YOLFTbeta
Vivos Therapeutics Inc

Vivos Therapeutics Inc

VVOS · NASDAQ · Healthcare / Medical Devices

0.098USD+0.00 (+2.40%)

Price History

Full chart

Market Stats

Previous Close0.0957
Open0.098
Day Range0.0915 – 0.0985
52-Week Range0.13 – 3.42
Volume720.72K
Market Cap2.83M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.88
Dividend Yield0.00%
Beta6.00
50-Day Avg0.2826
200-Day Avg0.9998

About

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. R. Kirk Huntsman
  • Employees268
  • Headquarters7921 Southpark Plaza, Littleton, CO, United States, 80120, USA
  • Websitehttps://www.vivos.com

Leadership

  • Mr. R. Kirk HuntsmanCo-Founder, Chairman of the Board & CEO · b. 1958
  • Mr. Bradford K. AmmanPrincipal Accounting Officer · b. 1962
  • Mr. Todd HuntsmanCo-Founder & Senior VP of Product and Technology
  • Ms. RaeAnn ByrnesCo-Founder and Senior VP of Events & Clinical Advisory Services
  • Ms. Susan McCulloughCo-Founder & Executive VP of Operations
  • Mr. Roman Nehemiah FranklinChief Financial Officer · b. 1984
  • Dr. Terry JonesSenior VP of Human Resources
  • Mr. Nicholas M. DeGennaroSenior Vice President of Mergers and Acquisition Group
  • Mr. Michael E. BruhnExecutive VP of Business Operations Integration
  • Jennifer HauserExecutive Assistant to CEO and Chairman & CFO

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.79M11.39M13.07M16.89M16.02M13.80M15.03M17.44M
Growth (%)-+200.43%+14.68%+29.23%-5.10%-13.87%+8.91%+16.05%
Cost of Revenue1.08M2.74M2.65M4.28M6.00M5.53M6.01M6.90M
Gross Profit2.71M8.66M10.41M12.60M10.02M8.27M9.02M10.54M
Gross Margin71.48%75.99%79.70%74.65%62.52%59.93%60.00%60.44%
Operating Expense11.05M19.23M22.45M32.08M35.05M25.57M20.19M30.44M
Operating Income-8.34M-10.58M-12.04M-19.47M-25.03M-17.30M-11.17M-19.89M
Operating Margin-219.82%-92.84%-92.15%-115.32%-156.21%-125.32%-74.32%-114.05%
EBITDA-7.73M-9.87M-11.24M-19.54M-23.18M-12.96M-10.55M-19.92M
EBITDA Margin-203.72%-86.59%-86.05%-115.73%-144.63%-93.92%-70.22%-114.21%
Net Income-8.44M-10.75M-12.06M-20.29M-23.84M-13.58M-11.14M-21.23M
Net Income Margin-222.54%-94.39%-92.28%-120.15%-148.81%-98.42%-74.09%-121.71%
R&D----200.00K100.00K100.00K-
R&D as % of Total Revenue----1.25%0.72%0.67%-
Interest Expense102.97K137.88K96.68K14.00K1.19M---
Interest Expense % of Total Revenue2.72%1.21%0.74%0.08%7.40%---

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.20M7.55M25.33M33.69M13.72M10.73M15.28M25.15M
Total Liabilities3.38M10.49M8.41M8.15M8.92M10.32M7.33M26.70M
Total Equity4.83M-2.94M16.92M25.54M4.80M411.00K7.95M-1.49M
Cash1.25M469.35K18.21M24.03M3.52M1.64M6.26M2.03M
Total Debt686.54K3.71M1.29M1.63M2.41M2.00M1.51M13.50M
Net Debt-568.18K3.24M-16.92M-22.40M-1.11M352.00K-4.75M11.47M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.31M-5.34M-5.68M-15.73M-19.59M-11.95M-12.69M-15.26M
Investing Cash Flow-1.12M86.22K-120.25K-2.61M-924.00K-853.00K-568.00K-7.53M
Financing Cash Flow5.25M4.47M23.54M24.17M7.36M10.92M17.88M18.56M
Capital Expenditure1.25M175.60K120.25K2.40M924.00K803.00K568.00K2.34M
Free Cash Flow-6.56M-5.52M-5.80M-18.13M-20.51M-12.75M-13.26M-17.60M
Dividends Paid-3.76M3.72M-----
FCF to OCF123.53%103.29%102.12%115.23%104.72%106.72%104.48%115.34%
Dividend Paid to FCF--68.16%-64.09%-----

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 14, 2020Mar 25, 2021May 17, 2021Aug 12, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Dec 20, 2022Mar 30, 2023Jun 8, 2023Aug 16, 2023Nov 14, 2023Mar 28, 2024May 14, 2024Aug 14, 2024Nov 14, 2024Mar 26, 2025May 15, 2025Aug 19, 2025Nov 19, 2025Mar 26, 2026May 20, 2026Aug 14, 2026Nov 18, 2026
EPS Estimate0.000.000.000.000.000.000.00-0.16-4.25-4.50-4.62-0.25-6.50-0.25-6.25-0.22-4.75-3.50-3.00-1.90-1.16-1.05-0.70-0.43-0.44-0.38-0.51-0.49-0.45-0.42-0.28
EPS Actual-0.23-0.23-0.27-0.18-0.18-0.16-0.23-0.88-4.75-4.75-6.50-0.34-8.01-0.28-6.50-0.201.49-3.89-3.08-3.05-1.63-0.60-0.40-0.28-0.45-0.55-0.49-0.58-0.52-0.31-
Surprise--------450.00%-11.76%-5.56%-40.69%-36.00%-23.23%-12.00%-4.00%9.09%131.37%-11.14%-2.67%-60.53%-40.52%42.86%42.86%34.88%-2.27%-44.74%3.92%-17.17%-15.56%26.19%-
Timing------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap2.83M
Enterprise Value14.80M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.14
Price / Book6.86
EPS-1.88
Book Value-0.339
Revenue (TTM)20.90M
Gross Profit (TTM)12.94M
EBITDA-20.76M
Profit Margin-121.79%
Operating Margin-93.64%
Return on Equity-8585.26%
Return on Assets-56.19%
Shares Outstanding20.12M
Shares Float19.10M
Beta6.00
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 2 analystsTarget 2.12
  • Strong Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
3.90%
Insiders
12.00%
Retail / Other
84.10%

Top Institutional Holders

  • Armistice Capital, LLC
    1.12M12.02%
  • Vanguard Capital Management, LLC
    273.33K2.94%
  • Geode Capital Management, LLC
    95.54K1.03%
  • Commonwealth Equity Services, LLC
    42.50K0.46%
  • IHT Wealth Management, LLC
    41.06K0.44%
  • National Asset Management Inc
    38.07K0.41%
  • Centurion Wealth Management LLC
    35.68K0.38%
  • Vanguard Fiduciary Trust Co
    30.83K0.33%
  • BlackRock Inc
    27.82K0.30%
  • XTX Topco Ltd
    25.12K0.27%
  • State Street Corp
    24.92K0.27%
  • Sequoia Financial Advisors LLC
    24.00K0.26%
  • Acorn Wealth Advisors, LLC
    14.78K0.16%
  • Northern Trust Corp
    12.51K0.13%
  • UBS Group AG
    11.05K0.12%
  • Tower Research Capital LLC
    7.39K0.08%
  • Advisor Group Holdings, Inc.
    1.14K0.01%

Top Fund Holders

  • Fidelity Extended Market Index
    60.77K0.65%
  • Fidelity Total Market Index
    12.07K0.13%
  • Fidelity Series Total Market Index
    8.35K0.09%

Stock Splits

  • Oct 27, 20231:25